Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Recruiting now
Conditions studied: Breast Cancer, Lung Cancer, Multiple Myeloma, Ovarian Cancer, Acute Myelogenous Leukemia
In brief
The goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic care planning system (CPS) with remote symptom monitoring that is used in routine care for cancer patients on active treatment. Patients will complete a baseline survey in person using a secured device or remotely using their own electronic device in a location of their choice. Weekly electronic patient reported outcome (PRO) surveys are collected from the patients using the Carevive platform for a minimum of 12 weeks. Patients may continue weekly surveys as long as they are receiving treatment.
Key facts
- Study ID
- NCT05974150
- Run by
- Carevive Systems, Inc.
- People needed
- 25
- Starts
- 2023-07-19
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-02-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All participants must be 18 years of age or older.
- Subjects may be any stage and anywhere in the treatment continuum.
- Subject participants must have a diagnosis of a breast, lung, AML, ovarian cancer or multiple myeloma.
- Subjects must be able to complete on-line surveys using a cell phone, tablet, or computer.
- All participants must be able to understand English.
You may not qualify if…
- Any patient who cannot understand written or spoken English.
- Any patient without the ability to complete on-line surveys using a cell phone, tablet, or computer.
- Any patient on a treatment clinical trial.
- Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C and D).
Where it is running
- Cleveland Clinic Mercy Hospital — Canton, Ohio, United States (enrolling)
- University Hospitals Seidman Cancer Center — Cleveland, Ohio, United States (enrolling)
- Tri-County Hematology & Oncology Associates, Inc. — Massillon, Ohio, United States (enrolling)
- Northshore University Health System — Evanston, Illinois, United States (enrolling)
- Duke — Durham, North Carolina, United States
- Univeristy of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States
- Yale Cancer Center — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.